Skip to main content
Springer logoLink to Springer
. 2013 May 15;246(6):453–466. doi: 10.1007/s00232-013-9557-4

Interactions of Alkylphosphocholines with Model Membranes—The Langmuir Monolayer Study

Anita Wnętrzak 1, Kazimierz Łątka 1, Patrycja Dynarowicz-Łątka 2,
PMCID: PMC3682106  PMID: 23673723

Abstract

Alkylphosphocholines (APCs) belong to a class of synthetic antitumor lipids, which are new-generation anticancer agents. In contrast to traditional antitumor drugs, they do not attack the cell nucleus but, rather, the cellular membrane; however, their mechanism of action is not fully understood. This work compared the interactions of selected APCs [namely, hexadecylphosphocholine (miltefosine), octadecylphosphocholine and erucylphosphocholine] with the most important membrane lipids [cholesterol, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC)] and examined their influence on a model membrane of tumor and normal cells. As a simple model of membranes, Langmuir monolayers prepared by mixing cholesterol either with a saturated phosphatidylcholine (DPPC), for a normal cell membrane, or with an unsaturated one (POPC), for a tumor cell membrane, have been applied. The APC–lipid interactions, based on experimental surface pressure (π) versus mean molecular area (A) isotherms, were analyzed qualitatively (with mean molecular area values) as well as quantitatively (with the ΔG exc function). Strong attractive interactions were observed for mixtures of APCs with cholesterol, contrary to the investigated phosphatidylcholines, for which the interactions were found to be weak with a tendency to separation of film components. In ternary monolayers it has been found that the investigated model systems (cholesterol/DPPC/APC vs cholesterol/POPC/APC) differ significantly as regards the interactions between film-forming molecules. The results demonstrate stronger interactions between the components of cholesterol/POPC/APC monolayers compared to cholesterol/POPC film, mimicking tumor cell membranes. In contrast, the interactions in cholesterol/DPPC/APC films were found to be weaker than those in the cholesterol/DPPC system, serving as a model of healthy cell membranes, thus proving that the incorporation of APCs is, from a thermodynamic point of view, unfavorable for binary cholesterol/DPPC monolayers. It can be concluded that the composition of healthy cell membranes is a natural barrier preventing the incorporation of APCs into normal cells.

Keywords: Alkylphosphocholine, Model membrane, Langmuir monolayer, Interaction

Introduction

To gain insight into the mechanism of physiological activity (mode of action, selectivity, toxicity) of biomolecules acting at the cellular membrane level, different methods can be applied, which are usually based on examining the interactions between a bioactive molecule and cellular membrane components. These interactions can be studied in natural systems, either isolated or not (living cells), or in membrane models. The former are highly variable and complicated and, thus, provide only a general view on a particular problem of interest, while the latter have the advantage of being simple and well-defined, therefore enabling the study of a specific aspect of a given phenomenon (Maget-Dana 1999).

Many different membrane models (reviewed in Peetla et al. 2009; Chan and Boxer 2007) have been applied to investigate the interactions between biochemicals and membrane components. Most popular are Langmuir monolayers (Peetla et al. 2009), liposomes or vesicles (Kell 1981), black lipid membranes (Ottova and Tien 1997) and surface-confined membrane systems (Richter et al. 2006). Although none of these models is perfect and fully universal (advantages and disadvantages of using the above-mentioned membrane models are discussed in Hąc-Wydro and Dynarowicz-Łątka 2008), the Langmuir monolayer technique, the principles of which can be found elsewhere (Gaines 1966), is a potent and frequently applied method for mimicking cellular membranes (Maget-Dana 1999; Hąc-Wydro and Dynarowicz-Łątka 2008; Brockman 1999) and very useful to study biomolecule–membrane interactions. These interactions can be considered crucial for understanding the mode of action of drugs acting on the membrane level (Maget-Dana 1999; Hąc-Wydro and Dynarowicz-Łątka 2008).

A good example of membrane-targeted drugs are synthetic analogues of lysophosphatidylcholine (Fig. 1a), generally termed alkyllysophospholipids (Gajate and Mollinedo 2002) (Fig. 1b), known for their anticancer properties. Attempts to find the minimal moiety in the phospholipid structure that maintains antitumor properties have led to the discovery of alkylphosphocholines (APCs) (Fig. 1c) (Eibl et al. 1992) and subsequent synthesis of their first homologue, hexadecylphosphocholine (HePC, miltefosine) (Fig. 2a) (Eibl and Unger 1990).

Fig. 1.

Fig. 1

General chemical structures of a lysophosphatidylcholine (LPC), b alkyllysophospholipid (ALP) and c alkylphosphocholine (APC)

Fig. 2.

Fig. 2

General chemical structures of a hexadecylphosphocholine (HePC), b octadecylphosphocholine (OcPC) and c erucylphosphocholine (ErPC)

The main disadvantage of using this drug was its inapplicability in oral administration due to severe gastrointestinal side effects and hemolysis upon intravenous injections. In order to overcome these problems, chemical modifications in the structure of APCs have been made; i.e., the hydrophobic part was modified either by its elongation [as exemplified by octadecylphosphocholine (OcPC) (Fig. 2b)] and/or by introduction of a double bond [as exemplified by erucylphosphocholine (ErPC) (Fig. 2c)] (Berger et al. 1998; Van der Luit et al. 2007; Rübel et al. 2006).

These membrane-targeted drugs, before affecting vital functions inside the cell—such as cell proliferation, cell cycle progression, differentiation, invasion and angiogenesis (Takai et al. 2008)—have to penetrate through the biomembrane. So far, little is known about how APCs interact with membrane constituents. Also, it is still unclear which membrane component is responsible for the high selectivity of APCs, i.e., targets the drug molecule to the tumor cell membrane, sparing the normal cells. To gain a deeper insight into these issues, it is of utmost importance to (1) examine systematically the interactions between the drugs and cellular membrane components and (2) compare the effect of APCs on model tumors and healthy cell membranes.

For this purpose, in the first step of our investigations, we selected three main membrane lipids [i.e., cholesterol, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC)] to study their interactions with selected APCs, having the same polar part and differing in the length of the hydrocarbon chain and saturation degree, namely, HePC, OcPC and ErPC. Cholesterol was chosen because of its crucial role in regulating membrane physicochemical properties in eukaryotic cells (Crane and Tamm 2004) as well as its involvement in the formation of ordered lipid rafts (Fan et al. 2010), which have been hypothesized to be a site of action of synthetic antitumor lipids (Heczkova and Slotte 2006; Van der Luit et al. 2007). DPPC and POPC, on the other hand, are the most abundant phospholipids building the biomembranes; and their proportion significantly differs in normal versus tumor membranes (Agatha et al. 2001). It is known that the membrane of healthy cells contains a higher amount of cholesterol and saturated phospholipids, whereas tumor cellular membrane is characterized by the presence of unsaturated lipids in higher amounts (Klock and Pieprzyk 1979). Therefore, the cancer cell membrane is more fluid compared to the normal cell membrane (Inbar et al. 1977). With the Langmuir monolayer technique it is possible to model cell membranes of healthy and cancerous cells and monitor changes in membrane properties caused by the addition of the investigated APCs, which was done in the second part of our study. For our research we chose leukemic cell membranes, composed of cholesterol and POPC, and normal cellular leucocyte membranes, containing cholesterol and DPPC.

We believe that our investigations will have lead to a better understanding of the membrane activity of alkylphospholipids, one of the most interesting and efficient antineoplastic agents.

Materials and Methods

The following materials were purchased and used: OcPC (AG Scientific, San Diego, USA), HePC (Avanti Polar Lipids, Alabaster, USA), cholesterol (Sigma, St. Louis, USA) and POPC and DPPC (Avanti Polar Lipids, Alabaster, USA). All of these products were of high purity (>99 %) and used as received. ErPC was kindly supplied by Aeterna Zentaris GmbH (Frankfurt, Germany). The investigated compounds were dissolved in a chloroform:methanol (Sigma-Aldrich, St. Louis, USA) 9:1 v/v mixture with a typical concentration of 0.2–0.5 mg/ml. Mixed solutions were obtained by mixing proper volumes of the respective stock solutions. Membrane models of leukemic and healthy cells were prepared based on Tsuchiya et al. (2002). In order to model the normal leucocyte cell membrane, cholesterol and DPPC were mixed in a proportion of 0.67, while tumor cell membrane was formed by mixing cholesterol with POPC in a ratio of 0.25.

The experiments were performed using Langmuir trough (total area = 600 cm2) placed on an antivibration table. Surface pressure (π) was measured with an accuracy of ±0.1 mN/m using a Wilhelmy plate made of chromatography paper (Whatman Chr1; Whatman, Piscataway, NJ). Mixtures containing APCs (mole fraction X APCs = 0.1–0.9) were prepared from stock solutions. Mixed monolayers were obtained by dropping the spreading solutions onto the water surface (ultrapure water produced by a Nanopure water purification system [APS Water, Lake Balboa, CA] coupled to a Milli-Q water purification system, resistivity = 18.2 MΩ cm) using a microsyringe (Hamilton, Reno, NV). The average number of molecules spread onto the water surface (pH 5.6) in a single experiment was ca. 4.54 × 1016. All experiments were performed at 20 °C. The subphase temperature was controlled to within 0.1 °C by a circulating water system from Julabo (Allentown, PA). After spreading, 10 min was allowed for the solvent to evaporate. Afterward compression was initiated with a barrier speed of 11 Å2/(molecule min). Each experiment was repeated two or three times to ensure high reproducibility of the obtained isotherms to ±2 Å2.

The above-mentioned conditions were chosen as optimal for performing Langmuir monolayer experiments for the studied APCs. However, one has to be aware of the potential errors resulting from using a Teflon barrier, spreading solvent (chloroform) of greater density than water and use of a Wilhelmy plate made of filter paper (for details, see Brzozowska and Figaszewski 2002).

Results

Isotherms of Pure Components

In the first step of our studies, three investigated APCs (HePC, OcPC, ErPC) and selected membrane lipids (cholesterol, DPPC, POPC) were studied alone in Langmuir monolayers.

Regarding the isotherms for pure membrane lipids, their characteristics are very well known and our results are in a good agreement with the data already published (see, e.g., Cadena-Nava et al. 2006 for cholesterol; for DPPC Klopfer and Vanderlick 1996; Duncan and Larson 2008; Crane et al. 1999; and for POPC Yun et al. 2003). Cholesterol forms very condensed monolayers and collapses at a surface pressure of about 44 mN/m, while DPPC exhibits a characteristic transition region (at ca. 5 mN/m), ascribed to orientation changes of molecules upon compression, and collapses at ca. 63 mN/m. On the other hand, POPC forms a liquid-expanded monolayer without any visible transition in the course of the isotherm and has a lower collapse pressure (50 mN/m) compared to the saturated phospholipid (DPPC).

Figure 3 confirms that the studied APCs are capable of forming monomolecular layers at the free water surface. They all form liquid-type films, as proved by the compression moduli C −1S = −A (dπ/dA) (Davies and Rideal 1963) values, shown in the inset. Comparing maximum C −1S values, it is evident that upon increasing of the hydrocarbon chain length, the monolayer successively becomes more condensed. Another characteristic feature is that upon elongation of the hydrophobic part of the APC molecule, the film becomes more stable, as indicated by higher values of collapse pressures (π coll). All of the characteristic parameters for the investigated APC monolayers are summarized in Table 1.

Fig. 3.

Fig. 3

Surface pressure (π)–area (A) isotherms of HePc, OcPC and ErPC spread at the air/water interface at 20 °C. Inset Compression modulus (C −1s)–surface pressure (π) dependencies

Table 1.

Characteristic parameters of HePC, OcPC and ErPC monolayers recorded at 20 °C

“Lift-off” (Å2/molecule) A 02/molecule) π coll (mN/m) A coll2/molecule) C −1s max (mN/m)
HePC 98 78 31 32 41
OcPC 70 68 38 28 63
ErPC 93 75 44 40 78

Two-Component Monolayers

Since the investigated APCs were proved to form floating monolayers on aqueous subphases, the Langmuir monolayer technique can be applied for studying their interactions with membrane lipids.

Monolayers of HePC, OcPC and ErPC mixed with membrane lipids (cholesterol, DPPC and POPC) were prepared for five different mole fractions of APCs (X APC): 0.1, 0.3, 0.5, 0.7 and 0.9. The resulting isotherms are shown in Figs. 4, 5, 6a–c.

Fig. 4.

Fig. 4

Surface pressure (π)–area (A) isotherms for APCs, cholesterol and their mixtures (ac). Collapse pressure (π coll) versus mixed film composition (XAPCs) plots (df). Compression modulus (C −1s)–surface pressure (π) dependencies (gi)

Fig. 5.

Fig. 5

Surface pressure (π)–area (A) isotherms for APCs, DPPC and their mixtures (ac). Collapse pressure (π coll) versus mixed film composition (XAPCs) plots (df). Compression modulus (C −1s)–surface pressure (π) dependencies (gi)

Fig. 6.

Fig. 6

Surface pressure (π)–area (A) isotherms for APCs, POPC and their mixtures (ac). Collapse pressure (π coll) versus mixed film composition (XAPCs) plots (df). Compression modulus (C −1s)–surface pressure (π) dependencies (gi)

Let us first discuss mixed systems with cholesterol (Fig. 4). Looking at the isotherms, it is seen that cholesterol exerts a condensing effect on monolayers from all the studied APCs. The π–A isotherms of pure cholesterol and X APC = 0.1 are very similar, while those for X APC = 0.3 and 0.5 have their lift-off areas shifted toward smaller values in respect to the monolayer of cholesterol. All of the remaining mixed isotherms of a higher proportion of APCs are similar in shape to the respective APCs; however, they are shifted toward smaller areas in respect to pure antitumor lipids.

To characterize the physical state of the investigated monolayers, compression moduli values were calculated from the isotherm data points and plotted as a function of surface pressure (Fig. 4g–i). The highest values of compression moduli, corresponding to the maxima on the C −1S = f(π) curves, were reached for pure cholesterol (ca. 1,000 mN/m) and mixed monolayers of X APC = 0.1–0.3, which are all of solid type. On the other hand, pure monolayers of APCs as well as mixtures containing an excess of APCs form liquid-type films.

To gain insight into the miscibility of APC/cholesterol systems, collapse pressure values have been plotted versus film composition (Fig. 4d–f). According to the phase rule, if two components are miscible in monolayers, the collapse pressure varies with mixed film composition (Crisp 1949; Wu and Huntsberger 1969). For HePC and OcPC the behavior is similar; i.e., cholesterol-rich monolayers can be clearly identified as miscible as their collapse pressures vary with film composition, contrary to films containing HePC or OcPC in excess (X ≥ 0.7), for which the collapse pressure remains constant. Interestingly, for a mixture containing X OcPC = 0.7, two collapses appear in the course of the isotherm. The first collapse occurs at a pressure close to the value of π coll for pure OcPC, while the other occurs at an elevated pressure (53 mN/m). In general, the presence of two independent collapses in the course of an isotherm from two film-forming molecules, corresponding to collapse pressure values for pure components, is evidence of their immiscibility in a monolayer (Dynarowicz-Łątka and Kita 1999). The first collapse corresponds to the ejection of a substance collapsing at lower pressures, while the other one collapses at higher pressure. Thus, for the discussed mixture of X OcPC = 0.7 it is evident that at a lower collapse pressure OcPC is first expelled from the monolayer and afterward, at a higher pressure, the remaining component (cholesterol) collapses. Similar behavior of two collapses can be expected for X OcPC = 0.9; however, the second collapse is not visible as it is expected to occur at a very low area (due to a small proportion of cholesterol in the mixed monolayer), which is out of the moving barrier range.

From analysis of the plots of π coll versus film composition it may be deduced that the miscibility of HePC and OcPC with cholesterol depends on mixed film composition, i.e., for films rich in cholesterol both components mix in monolayers, contrary to films containing an excess of antitumor lipid, wherein film separation occurs.

For monolayers composed by ErPC and cholesterol, due to very similar values of collapse pressures of pure components and their mixtures, the conclusion regarding miscibility based on collapse pressure analysis is not as evident as in the former cases. It looks like the system is miscible within the whole range of mole fractions; however, further analysis based on mean molecular area values and excess free energy values is required for this particular mixture and will be discussed later.

In Fig. 5a–c the isotherms for mixtures with DPPC are presented. As can be seen, the course of the isotherm changes systematically upon addition of APCs, from the shape similar to pure DPPC to that characteristic for pure APC. For mixtures of X APC = 0.1, the plateau region characteristic for DPPC (reflecting the phase transition between liquid-expanded and liquid-condensed states) is observed. With the increase of APC content in a monolayer, this plateau region gradually shortens, shifts to higher pressures and finally disappears. A characteristic feature of mixed films of X HePC = 0.3–0.7, X OcPC = 0.3–0.5 and X ErPC = 0.3 is the presence of two collapses in the course of the isotherms. From the collapse pressure values plotted versus film composition (Fig. 5d–f) it can be observed that both the first and the second collapse remain nearly constant upon changing the components’ proportion; the first collapse occurs at a surface pressure close to that for pure APC, while the second occurs at a similar pressure to that for pure DPPC. This may suggest immiscibility and phase separation in mixtures with DPPC.

Figure 6a–c shows the isotherms recorded for mixtures with POPC. In this case, mixed monolayers are situated between those obtained for the respective one-component films. The monolayers of both APCs and POPC as well as their mixtures are of liquid character. The isotherms lack any phase transition. The collapse pressure changes almost linearly with film composition for HePC-containing film (Fig. 6d). For the remaining systems, the collapse pressure values for mixtures with either OcPC or ErPC are very similar to that for pure POPC. Therefore, a further thermodynamic analysis is required to gain insight into the miscibility of components in these mixtures.

For a qualitative analysis of the interactions between APCs and membrane lipids, the mean molecular area values (obtained directly from the isotherms) versus film composition have been plotted (Fig. 7).

Fig. 7.

Fig. 7

Mean molecular area (A 12) versus mixed film composition (XAPCs) plots for mixtures of APCs with investigated lipids at different constant surface pressures

For mixtures with cholesterol (Fig. 7a, d, g), negative deviations from ideal behavior are observed, indicating attractive interactions occurring between all of the investigated APCs and cholesterol. The extent of deviations is dependent on surface pressure and film composition. For HePC and OcPC/cholesterol mixtures, the most significant deviations are seen at a 1:1 proportion of the components, while for the ErPC/cholesterol system the strength of attractive interactions seems to be comparable for a broad composition range (XErPC = 0.3–0.9). Not only the film composition but also the surface pressure influences the strength of interactions; namely, at elevated surface pressures, the interactions are stronger, which is logical considering the closer molecular packing.

Different behavior is seen for mixtures with DPPC (Fig. 7b, e, h). Positive deviations, indicating repulsive interactions, confirm immiscibility and phase separation between molecules in HePC and OcPC/DPPC monolayers. For ErPC mixed with DPPC, small positive deviations appear only at low π, while at higher pressures slight negative deviations are seen. For mixtures with POPC (Fig. 7c, f, i), in general, the extent of interactions is smaller compared to DPPC (slightly repulsive interactions are observed for monolayers containing HePC and OcPC and attractive ones for ErPC).

Thermodynamic Analysis of APC/Lipid Monolayers

To quantify the above-mentioned interactions, values of the excess free enthalpy changes (ΔG exc) at different π were calculated from the isotherm data points (Fig. 8) using the following equation (Pagano and Gershweld 1972)

ΔGexc=NA0πAexcdπ 1

Fig. 8.

Fig. 8

Excess free enthalpy of mixing (ΔG exc) versus mixed film composition (XAPCs) plots for mixtures of APCs with investigated lipids at different constant surface pressures

where A exc is defined as the difference between the mean molecular area A 12 observed at a given π value for a particular mole ratio of the components and the ideal mean molecular area A id12, which is defined as the weighted average of the mean molecular areas (A 1 and A 2) observed for the one-component monolayers at the same surface pressure (A id12 = A 1 X 1 + A 2[1 − X 1], where X 1 is the mole ratio of component 1 in the binary film).

Strong negative values of ΔG exc for mixtures with cholesterol are indicative of potent attractive interactions between APCs and cholesterol molecules. The occurrence of a minimum implies that the influence of molecular interactions on film stability was most significant at that very composition. Such strong attractive interactions may result from the formation of surface complexes, as has been postulated by other authors (Seoane et al. 1998; Saint-Pierre-Chazalet et al. 1988; Gershfeld 1978; Albrecht et al. 1981; Gong et al. 2002) to interpret the deviations from ideality observed for a particular mixture composition. For the investigated HePC and OcPC mixtures with cholesterol, due to the strongest interactions at XAPC = 0.5, it may be postulated that APC–cholesterol complexes of 1:1 stoichiometry are formed at the surface. Further elongation of the hydrophobic part of the molecule together with the introduction of a double bond (ErPC) causes the interactions with cholesterol to be similar within a wide composition range and their strength gradually increases upon addition of ErPC into the film, without any clear minimum in the curve.

Differences in interactions of ErPC versus HePC and OcPC are more pronounced in mixtures with phospholipids. Independently of the degree of unsaturation of the hydrophobic chains of phosphatidylcholines (DPPC or POPC), both HePC and OcPC show repulsive interactions, in contrast to ErPC, for which small attractive intermolecular forces are observed. This proves that although the elongation of the hydrophobic chain length from C16 to C18 does not change much the behavior of APCs mixed with cholesterol or phospholipids, a further increase of the hydrocarbon chain length to C22 together with the presence of a double bond exerts a more significant change in the nature and strength of the interaction, especially when phospholipids are concerned.

Influence of APCs on Model Membranes—Three-Component Monolayers

In order to gain insight into the influence of the investigated APCs on normal and tumor cells, their membranes were modeled with Langmuir monolayers composed of cholesterol and phosphatidylcholines (DPPC or POPC) in the proportion specified above (“Materials and Methods” section). The investigated APCs were added into both model membranes in various concentrations (X APC = 0, 0.1, 0.3, 0.5, 0.7, 0.9, 1), keeping the cholesterol/phosphatidylcholine proportion in the respective model systems constant.

The surface pressure (π)–area (A) isotherms recorded for binary cholesterol/phosphatidylcholine model membranes are shown in Fig. 9 together with the isotherms for pure components, which are included for the purpose of comparison.

Fig. 9.

Fig. 9

Surface pressure (π)–area (A) isotherms for binary cholesterol/phosphatidylcholine model membranes. a normal, b tumor. Insets compression modulus (C −1s)–surface pressure (π) dependencies for model membranes

The curves for the respective model systems differ significantly in their shape and position; i.e., the isotherm for normal cellular membrane is steeper and is located at smaller areas compared to that representing a tumor system, which has the character of a liquid-type monolayer.

The isotherms obtained for ternary cholesterol/phosphatidylcholine/APC monolayers of various drug concentration are presented in Figs. 10 and 11.

Fig. 10.

Fig. 10

Surface pressure (π)–area (A) isotherms for chol/DPPC/APC system

Fig. 11.

Fig. 11

Surface pressure (π)–area (A) isotherms for chol/POPC/APC system

The isotherms alone are not very illustrative regarding the influence of APCs on model membranes in contrast to the parameters that can be determined from the experimental isotherm data points, such as the excess free enthalpy of mixing (ΔG exc) values. Since the correlation between the properties of lipid monolayers and bilayers has been found in the surface pressure region of 30–35 mN/m (Marsh 1996), the results have been analyzed at π = 30 mN/m (Fig. 12).

Fig. 12.

Fig. 12

Excess free enthalpy of mixing (ΔG exc) versus mixed film composition (XAPCs) plots for ternary cholesterol/phosphatidylcholine/APC systems at 30 mN/m

From Fig. 12 it is evident that APCs affect both membranes, though in opposite ways. Negative values of ΔG exc demonstrate a favorable effect between APCs and model tumor membrane, evidenced by the stronger interactions between the components of ternary cholesterol/POPC/APC monolayers compared to cholesterol/POPC film. In contrast, positive values of ΔG exc for cholesterol/DPPC/APC films show that the interactions are weaker (less attractive or more repulsive) and the film is thermodynamically less stable versus the cholesterol/DPPC system, modeling the normal membrane. Therefore, it may be concluded that the incorporation of APCs to normal cell membranes is thermodynamically unfavorable.

Discussion

Three synthetic APCs with antineoplastic activities—HePC, OcPC and ErPC—were investigated in Langmuir monolayers formed by membrane lipids, serving as a model of biological membranes. In the first step of our investigations, the above-mentioned APCs were studied in mixtures with single membrane lipids, such as cholesterol, DPPC and POPC. Although it is well known that a biological membrane is a multicomponent system, in order to analyze the results obtained for more complicated mixtures (cholesterol/DPPC and cholesterol/POPC, mimicking membranes of normal and tumor cells), such experiments were necessary.

Studying mixtures of APCs and cholesterol, strong attractive interactions were found between both components in monolayers. The influence of the drugs on cholesterol films was analyzed in a wide range of monolayer compositions and at various surface pressures. It was found that the presence of cholesterol caused the contraction of monolayers from APCs and the mixed film became more condensed upon increasing the proportion of cholesterol. Thermodynamic analysis of APC/cholesterol mixtures proved that the strongest interactions (ΔG exc ~2500 J/mol at 30 mN/m, 20 °C) between the two components occurred when either HePC or OcPC was mixed with cholesterol in a 1:1 proportion. In the case of ErPC, strong interactions with cholesterol were observed within a wide range of mole fractions, without any particular composition showing significantly stronger interactions. Such a strong affinity between components suggests that cholesterol can be of importance in APC incorporation into cell membranes. Namely, molecules of APCs can get “immobilized” with cholesterol, and as a result, only a small amount of “free” drugs can permeate through the biomembrane, exerting its biological activity. Such a lower uptake of antitumor drugs into cellular membranes rich in cholesterol was observed for a synthetic alkyllysophospholipid analogue, edelfosine (Diomede et al. 1990). Although no direct correlation between the cellular level of cholesterol and APC (i.e., HePC) sensitivity was found (Fleer et al. 1993), among various cell lines those possessing the highest phospholipid-to-cholesterol ratio (the epidermoid cancer cell line KB) had the highest capacity for drug uptake, which can be understood based on the results reported here.

Considering phosphatidylcholines, our experiments were concentrated on examining the effect of APCs, being the major lipids of the cellular membrane. Among phosphatidylcholines, two compounds differing in the degree of saturation of the chains were studied, DPPC and POPC. The results for APC/DPPC and APC/POPC mixtures prove that, in general, their interactions are much weaker versus those with cholesterol. Such parameters of interaction, like A 12 or ΔG exc show either positive deviations from ideality (for HePC and OcPC mixed with either with DPPC or POPC) or, in the case of ErPC, small negative deviations at room temperature. From the calculated ΔG exc values it seems that the extent of interactions between APCs with the studied phosphatidylcholines is very similar, independently of the different degree of saturation of the two phospholipids.

To summarize, the above results allow us to conclude that cholesterol can play a more important role in the transport of APCs throughout the biological membrane compared to both investigated phospholipids, which seem to be less important in this aspect.

The affinity of APCs to the studied membrane lipids can also be explained based on the molecular geometry of interacting molecules (Israelachvili 2011). Geometric packing of molecules can be expressed in terms of a dimensionless critical packing parameter, s, which depends on the headgroup area (a), volume (V) and critical length (l c) of the hydrocarbon chain:

s=Va·lc 2

Values of a, V and l c are characteristic for a given molecule and can be calculated using the following equations:

V=(27.4+26.9nc)[Å3] 3
lc=(1.5+1.265nc)[Å3] 4

where n c is the number of carbon atoms in the chain; 27.4 and 26.9 Å3 are the volumes of the CH3 and CH2 groups, respectively; 1.265 is the length of the C–C bond; and 1.5 is the radius of the CH3 group. The value of a is affected by such parameters as the volume of the headgroup, its charge as well as the possibility of hydrogen bond formation and strength; therefore, its value is difficult to estimate. For phosphatidylcholine and cholesterol these values have been calculated to be 71.7 and 19 Å2, respectively (Kumar 1991). The value of s determines the type of lipid aggregation (Israelachvili 2011).

Our calculations revealed that APCs possess a conical shape—HePC and OcPC, cone; ErPC, truncated cone (see Table 2). In combination with cholesterol of an inverted truncated cone, such an arrangement of opposite molecular geometries ensures favorable packing of APCs and cholesterol, resulting in strong attractive intermolecular interactions, observed in Fig. 5a. These results can also explain the lack of hemolytic activity of ErPC in comparison to other APCs (Jendrossek et al. 2003). Namely, a clear minimum at a 1:1 molar fraction in ΔG exc = f(X HePC/OcPC) graphs implies that up to this proportion HePC and OcPC are bound with cholesterol in the form of complexes and no excess of molecules of these alkylphoshocholines remains at the surface. However, upon exceeding the amount of these drugs above the 1:1 proportion, “free” (unbound with cholesterol) molecules of HePC and OcPC are present, which are responsible for the hemolytic activity. The system ErPC/cholesterol behaves differently; i.e., practically within the whole mole fraction (except for the region of very low ErPC content) drug molecules strongly interact with cholesterol. This allows us to understand the difference between ErPC and other investigated APCs in terms of hemolysis.

Table 2.

Molecular packing parameters of membrane lipids and APCs

Component Parameters
a2) l c (Å) V3) s Shape
Lipids
 Cholesterol 19 17.250 400 1.22 graphic file with name 232_2013_9557_Figa_HTML.gif
 DPPC 71.7 20.475 847 0.57 graphic file with name 232_2013_9557_Figb_HTML.gif
 POPC 71.7 20.475 910 0.619 graphic file with name 232_2013_9557_Figc_HTML.gif
APCs
 HePC 71.7 20.475 430.9 0.29 graphic file with name 232_2013_9557_Figd_HTML.gif
 OcPC 71.7 23.005 484.7 0.29 graphic file with name 232_2013_9557_Fige_HTML.gif
 ErPC 71.7 24.400 582.9 0.33 graphic file with name 232_2013_9557_Figf_HTML.gif

s Critical packing parameter; a headgroup area, the volume; V volume of hydrocarbon chain; l c critical length of hydrocarbon chain

On the other hand, phosphatidylcholine molecules are of a truncated cone shape. Therefore, a combination with conically shaped APCs does not meet the condition of geometrical complementarity, which explains weak APC/DPPC(POPC) interactions with a tendency to phase separation.

The results obtained for systems imitating natural membranes prove that the insertion of APCs modifies the properties of both model systems, though in a completely different way. The monolayers mimicking tumor and normal cell membranes are of different molecular organization due to different compositions of their component lipids. Cholesterol/DPPC film is more ordered and condensed than the cholesterol/POPC system as shown by higher compression modulus values found for normal cell model membrane compared to the tumor model system (Fig. 9, inset). Studies of mixed monolayers of cholesterol/DPPC (Dynarowicz-Latka et al. 2002) and cholesterol/POPC (Jurak 2013) prove that the affinity of cholesterol to DPPC is stronger than that to POPC. Therefore, the insertion of APCs molecules into a more liquid and less ordered cholesterol/POPC monolayer is much easier than the incorporation of drug molecules into cholesterol/DPPC film. This enables us to conclude that the membrane of normal cells is a natural barrier, preventing drug molecules from penetrating into healthy cells and explains the high selectivity of APCs.

Acknowledgement

Aeterna Zentaris GmbH (Frankfurt, Germany) is gratefully acknowledged for providing a sample of ErPC for investigations. The research was carried out with equipment (Langmuir trough) purchased thanks to the financial support of the European Regional Development Fund in the framework of the Polish Innovation Economy Operational Program (contract POIG.02.01.00-12-023/08).

References

  1. Agatha G, Häfer R, Zintil F. Fatty acid composition of lymphocyte membrane phospholipids in children with acute leukemia. Cancer Lett. 2001;173:139–144. doi: 10.1016/S0304-3835(01)00674-7. [DOI] [PubMed] [Google Scholar]
  2. Albrecht O, Gruler H, Sackmann E. Pressure–composition phase diagrams of cholesterol/lecithin, cholesterol/phosphatidic acid, and lecithin/phosphatidic acid mixed monolayers: a Langmuir film balance study. J Colloid Interface Sci. 1981;79:319–338. doi: 10.1016/0021-9797(81)90084-9. [DOI] [Google Scholar]
  3. Berger MR, Sobottka S, Konstantinov SM, Eibl H. Erucylphosphocholine is the prototype of i.v. injectable alkylphosphocholines. Drugs Today. 1998;34(Suppl E):73–81. [Google Scholar]
  4. Brockman H. Lipid monolayers: why use half a membrane to characterize protein–membrane interactions? Curr Opin Struct Biol. 1999;9:438–443. doi: 10.1016/S0959-440X(99)80061-X. [DOI] [PubMed] [Google Scholar]
  5. Brzozowska I, Figaszewski ZA. The equilibrium of phosphatidylcholine-cholesterol in monolayers at the air/water interface. Colloids Surf B Biointerfaces. 2002;23:51–58. doi: 10.1016/S0927-7765(01)00209-0. [DOI] [Google Scholar]
  6. Cadena-Nava RD, Martin-Mirones JM, Vázques-Martinez EA, Roca JA, Ruiz-Garcia J. Direct observations of phase changes in Langmuir films of cholesterol. Rev Mex Fis. 2006;52:32–40. [Google Scholar]
  7. Chan Y-HM, Boxer SG. Model membrane systems and their applications. Curr Opin Chem Biol. 2007;11:581–587. doi: 10.1016/j.cbpa.2007.09.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Crane JM, Putz G, Hall SB. Persistence of phase coexistence in disaturated phosphatidylcholine monolayers at high surface pressures. Biophys J. 1999;77:3134–3143. doi: 10.1016/S0006-3495(99)77143-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Crane JM, Tamm LK. Role of cholesterol in the formation and nature of lipids rafts in planar and spherical model membranes. Biophys J. 2004;86:2965–2979. doi: 10.1016/S0006-3495(04)74347-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Crisp DJ. A two-dimensional phase rule I. Derivation of a two-dimensional phase rule for plane interfaces. London: Butterworths; 1949. pp. 17–22. [Google Scholar]
  11. Davies JT, Rideal EK. Interfacial phenomena. New York: Academic Press; 1963. [Google Scholar]
  12. Diomede L, Bizzi A, Magistrelli A, Modest EJ, Salmona M, Noseda A. Role of cell cholesterol in modulating antineoplastic ether lipid uptake, membrane effects and cytotoxicity. Int J Cancer. 1990;46:341–346. doi: 10.1002/ijc.2910460234. [DOI] [PubMed] [Google Scholar]
  13. Duncan SL, Larson RG. Comparing experimental and simulated pressure-area isotherms for DPPC. Biophys J. 2008;94:2965–2986. doi: 10.1529/biophysj.107.114215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Dynarowicz-Łątka P, Kita K. Molecular interaction in mixed monolayers at the air/water interface. Adv Colloid Interface Sci. 1999;79:1–17. doi: 10.1016/S0001-8686(98)00064-5. [DOI] [Google Scholar]
  15. Dynarowicz-Łątka P, Seoane R, Miñones J, Jr, Velo M, Miñones J. Study of penetration of amphotericin B into cholesterol or ergosterol containing dipalmitoyl phosphatidylcholine Langmuir monolayers. Colloids Surf B Biointerfaces. 2002;25:249–263. [Google Scholar]
  16. Eibl H, Unger C. Hexadecylphosphocholine: a new and selective antitumor drug. Cancer Treat Rev. 1990;17:233–242. doi: 10.1016/0305-7372(90)90053-I. [DOI] [PubMed] [Google Scholar]
  17. Eibl H, Hilgard P, Unger C. Alkylphosphocholines: new drugs in cancer therapy. In: Unger C, Fleer EAM, Kötting J, Neumüller W, Eibl H, editors. Antitumoral activity of alkyl phoshpocholines and analogues in human leukemia cell lines. Basel: Karger; 1992. pp. 25–32. [DOI] [PubMed] [Google Scholar]
  18. Fan J, Sammalkorpi M, Haataja M. Formation and regulation of lipid microdomains in cell membranes: theory, modeling, and speculation. FEBS Lett. 2010;584:1678–1684. doi: 10.1016/j.febslet.2009.10.051. [DOI] [PubMed] [Google Scholar]
  19. Fleer EAM, Berkovic D, Eibl H, Unger C. Investigations on the cellular uptake of hexadecylphosphocholine. Lipids. 1993;28:731–736. doi: 10.1007/BF02535995. [DOI] [PubMed] [Google Scholar]
  20. Gaines GL., Jr . Insoluble monolayers at liquid–gas interfaces. New York: Interscience; 1966. [Google Scholar]
  21. Gajate C, Mollinedo F. Biological activities, mechanisms of action and biomedical prospect of the antitumor ether phospholipid ET-18-OCH3 (edelfosine), a proapoptotic agent in tumor cells. Curr Drug Metab. 2002;3:491–526. doi: 10.2174/1389200023337225. [DOI] [PubMed] [Google Scholar]
  22. Gershfeld NL. Equilibrium studies of lecithin–cholesterol interactions: I. Stoichiometry of lecithin–cholesterol complexes in bulk systems. Biophys J. 1978;22:469–488. doi: 10.1016/S0006-3495(78)85500-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Gong K, Feng S-S, Go ML, Soew PH. Effects of pH on the stability and compressibility of DPPC/cholesterol monolayers at the air–water interface. Colloid Surf A. 2002;207:113–125. doi: 10.1016/S0927-7757(02)00043-2. [DOI] [Google Scholar]
  24. Hąc-Wydro K, Dynarowicz-Łątka P. Biomedical applications of the Langmuir monolayer technique. Ann UMCS Chem. 2008;63:47–60. [Google Scholar]
  25. Heczkova B, Slotte JP. Effect of anti-tumor ether lipids on ordered domains in model membranes. FEBS Lett. 2006;580:2471–2476. doi: 10.1016/j.febslet.2006.03.079. [DOI] [PubMed] [Google Scholar]
  26. Inbar M, Goldman R, Inbar L, Bursuker I, Goldman B, Akstein E, Segal P, Ipp E, Ben-Bassat I. Fluidity difference of membrane lipids in human normal and leukemic lymphocytes as controlled by serum components. Cancer Res. 1977;37:3037–3041. [PubMed] [Google Scholar]
  27. Israelachvili JN. Intermolecular and surface forces. 3. New York: Academic Press; 2011. [Google Scholar]
  28. Jendrossek V, Müller I, Eibl H, Belka C. Intracellular mediators of erucylphosphocholine-induced apoptosis. Oncogene. 2003;22:2621–2632. doi: 10.1038/sj.onc.1206355. [DOI] [PubMed] [Google Scholar]
  29. Jurak M. Thermodynamic aspects of cholesterol effect on properties of phospholipid monolayers: Langmuir and Langmuir-Blodgett monolayer study. J Phys Chem B. 2013;117:3496–3502. doi: 10.1021/jp401182c. [DOI] [PubMed] [Google Scholar]
  30. Kell DB. Are liposomes good models for biomembranes? Trends Biochem Sci. 1981;6:8–9. [Google Scholar]
  31. Klock JC, Pieprzyk JK. Cholesterol, phospholipids, and fatty acids of normal immature neutrophils: comparison with acute myeloblastic leukemia cells and normal neutrophils. J Lipid Res. 1979;20:908–911. [PubMed] [Google Scholar]
  32. Klopfer KJ, Vanderlick TK. Isotherms of dipalmitoylphosphatidylcholine (DPPC) monolayers: features revealed and features obscured. J Colloid Interface Sci. 1996;182:220–229. doi: 10.1006/jcis.1996.0454. [DOI] [Google Scholar]
  33. Kumar VV. Complementary molecular shapes and additivity of the packing parameter of lipids. Proc Natl Acad Sci USA. 1991;88:444–448. doi: 10.1073/pnas.88.2.444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Maget-Dana R. The monolayer technique: a potent tool for studying the interfacial properties of antimicrobial and membrane-lytic peptides and their interactions with lipid membranes. Biochim Biophys Acta. 1999;1462:109–140. doi: 10.1016/S0005-2736(99)00203-5. [DOI] [PubMed] [Google Scholar]
  35. Marsh D. Lateral pressure in membranes. Biochim Biophys Acta. 1996;1286:183–223. doi: 10.1016/S0304-4157(96)00009-3. [DOI] [PubMed] [Google Scholar]
  36. Ottova AL, Tien HT. Self-assembled bilayer lipid membranes: from mimicking biomembranes to practical applications. Bioelectrochem Bioenerg. 1997;42:141–152. doi: 10.1016/S0302-4598(96)05098-2. [DOI] [Google Scholar]
  37. Pagano RE, Gershweld NL. A millidyne film balance for measuring intermolecular energies in lipid films. J Colloid Interface Sci. 1972;41:311–317. doi: 10.1016/0021-9797(72)90116-6. [DOI] [Google Scholar]
  38. Peetla C, Stine A, Labhasetwar L. Biophysical interactions with model lipid membranes: applications in drug discovery and drug delivery. Mol Pharm. 2009;6:1264–1276. doi: 10.1021/mp9000662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Richter RP, Berat R, Brisson AR. Formation of solid-supported lipid bilayers: an integrated view. Langmuir. 2006;22:3497–3505. doi: 10.1021/la052687c. [DOI] [PubMed] [Google Scholar]
  40. Rübel A, Handrick R, Lindner LH, Steiger M, Eibl H, Budach W, Belka C, Jendrossek V. The membrane targeted apoptosis modulators erucylphosphocholine and erucylphosphohomocholine increase the radiation response of human glioblastoma cell lines in vitro. Radiat Oncol. 2006;1:1–17. doi: 10.1186/1748-717X-1-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Saint-Pierre-Chazalet M, Thomas C, Dupeyrat M, Gary-Babo CM. Amphotericin B–sterol complex formation and competition with egg phosphatidylcholine: a monolayer study. Biochim Biophys Acta. 1988;944:477–480. doi: 10.1016/0005-2736(88)90519-6. [DOI] [PubMed] [Google Scholar]
  42. Seoane R, Miñones J, Conde O, Casas M, Iribarnegaray E. Molecular organisation of amphotericin B at the air–water interface in the presence of sterols: a monolayer study. Biochim Biophys Acta. 1998;1375:73–83. doi: 10.1016/S0005-2736(98)00137-0. [DOI] [PubMed] [Google Scholar]
  43. Takai N, Ueda T, Nasu K, Narahara H. Erucylphosphocholine shows a strong anti-growth activity in human endometrial and ovarian cancer cells. Gynecol Oncol. 2008;111:336–343. doi: 10.1016/j.ygyno.2008.08.004. [DOI] [PubMed] [Google Scholar]
  44. Tsuchiya H, Nagayama M, Tanaka T, Furusawa M, Kashimata M, Takeuchi H. Membrane-rigidifying effects of anti-cancer dietary factors. Biofactors. 2002;16:45–56. doi: 10.1002/biof.5520160301. [DOI] [PubMed] [Google Scholar]
  45. Van der Luit AH, Vink SR, Klarenbeek JB, Perrissoud D, Solary E, Verheij M, Blitterswijk WJ. A new class of anticancer alkylphospholipids uses lipid rafts as membrane gateways to induce apoptosis in lymphoma cells. Mol Cancer Ther. 2007;6:2337–2345. doi: 10.1158/1535-7163.MCT-07-0202. [DOI] [PubMed] [Google Scholar]
  46. Wu S, Huntsberger JR. Intermolecular interaction in some mixed polymer monolayers at the air–water interface. J Colloid Interface Sci. 1969;29:138–147. doi: 10.1016/0021-9797(69)90355-5. [DOI] [Google Scholar]
  47. Yun H, Choi Y-W, Kim NJ, Sohn D. Physicochemical properties of phosphatidylcholine (PC) monolayers with different alkyl chains, at the air/water interface. Bull Korean Chem Soc. 2003;24:377–383. doi: 10.5012/bkcs.2003.24.3.377. [DOI] [Google Scholar]

Articles from The Journal of Membrane Biology are provided here courtesy of Springer

RESOURCES